Pharmaceuticals, Biotechnology and Life Sciences
One of CARsgen Therapeutics’ leading drug candidates, CT053 fully human BCMA (B-Cell Maturation Antigen)-CAR-T cell for the treatment of patients suffering from relapsed/refractory multiple myeloma (rrMM), has received Investigational New Drug (IND) clearance from the United States Food and Drug Administration (FDA).
Japanese Ministry of Health, Labour, and Welfare has granted a second manufacturing and marketing approval for Myriad Genetics’ subsidiary, Myriad Genetic Laboratories, for BRACAnalysis Diagnostic System as a companion diagnostic with the PARP inhibitor, Lynparza, marketed by AstraZeneca and Merck.
ObsEva’s has recently cleared with the U.S. Food and Drug Administration (FDA) several important development issues for its oral oxytocin receptor antagonist nolasiban, which enables it to begin its U.S. Phase 3 clinical trial (IMPLANT 3) in the fourth quarter of this year or early 2020.
Arena Pharmaceuticals has dosed first patients in a trial called ELEVATE UC 52, which is the first of two pivotal trials within the Phase 3 registrational program designated to test etrasimod 2 mg in subjects with moderately to severely active ulcerative colitis (UC).
by: Lucy WyndhamYoga can Reduce the Severity of Rheumatoid Arthritis There are over 1.3 million Americans battling rheumatoid arthritis (RA)…
EUSA Pharma’s studies of Qarziba in treatment of high-risk neuroblastoma support the use of dinutuximab beta as standard-of-care immunotherapy for high-risk neuroblastoma patients.
Allergan and Gedeon Richter got the U.S. Food and Drug Administration approval for a supplemental New Drug Application (sNDA) for VRAYLAR (cariprazine) for expanded use to treat depressive episodes associated with bipolar I disorder (bipolar depression) in adults.
Ansun Biopharma has welcomed the first patient to its Phase 3 clinical trial to test DAS181 a recombinant sialidase protein that can cleave sialic acid, the virus receptors located on the surface of epithelial cells lining the human respiratory track.
Schreiner MediPharm developed the Patch-Safe specialty label for PS Marketing & Outsourcing GmbH, to be used for safe disposal of patches containing active ingredients.
The Business of Fashion claims that the candle market has risen by more than thirty percent over the last two years, and for good reason. Scented candles are comforting, great for setting the mood, and making your home smell down right delicious, but the dangers of scented paraffin candles might not be worth their mood-boosting qualities, as inhaling what they give off could be damaging to the lungs and more.